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The presence of SV40 viral particles in the environment of cynomolgus monkeys naturally infected with this virus has been analyzed by
testing waste of the cage samples.
SV40 was detected in 2/4 cages tested where mixed infection of SV40 and adenoviruses was observed after inoculation of virions
concentrated from cage waste in CV-1 cells. The detected SV40 strains were identical in the regions studied to strain W17, isolated at
National Institute for Biological Standards and Control, UK (NIBSC) from a (1/19) monkey kidney biopsy and contains an archetypal
regulatory region. The recovery of infectious SV40 virions from the cages provides information about the potential mechanism of
transmission of this virus.
D 2004 Elsevier Inc. All rights reserved.
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The discovery of the polyomavirus SV40 is tied to the
development and distribution of polio vaccines that were
inadvertently contaminated with the virus and distributed
worldwide potentially exposing several millions of persons
to the virus during 1955–1963 (Shah and Nathanson, 1976).
SV40 naturally infects a few species of Asiatic macaques,
especially Rhesus monkeys (revised in Shah et al., 1971). In
rhesus macaques, the virus multiplies readily producing
viremia and a high-tittered antibody response. In the wild,
only a small proportion of the juvenile macaques, but nearly
all adults, have SV40 antibodies (Meyers et al., 1962; Shah
and Southwick, 1965). This infection appears to be
subclinical, and the virus establishes a long-term latent
chronic infection in the kidneys and is excreted in the urine0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.09.007
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and transmission to nonimmune monkeys although the exact
manner of transmission of SV40 is not known (Hull, 1968).
Experimentally, nonimmune rhesus monkeys are readily
infected by the oral, intranasal, and subcutaneous route
leading to viremia and viruria. In captivity, SV40 is readily
transmitted to other macaques in contact with infected
rhesus as is the case for cynomolgus macaques and African
green monkeys (Shah and Nathanson, 1976). The presence
of SV40 in the brain of immunodeficient monkeys
demonstrated that SV40 is neurotropic in addition to being
kidney tropic. A role for SV40 in the etiology of some brain
tumors and in the development of central nervous system
lesions distinct from PML has been suggested (Hurley et al.,
1997; Simon et al., 1999). Recently, reports linking SV40
and human tumors have accumulated, and the potential role
of SV40 in cancer etiology requires serious consideration.
SV40 has been associated with mesotheliomas and different
types of brain tumors such as ependymomas and choroid
plexus carcinomas. In addition to mesotheliomas and brain
tumors, SV40 has been associated with other human tumors2004) 1–7
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kin’s lymphomas, AIDS-related lymphomas, peripheral
blood cells, sperm fluids, and kidney tissue (Arrington
and Butel, 2001). In previous studies, no SV40 virions have
been detected in urban sewage samples containing, almost
all of them, human polyomaviruses JCV and BKV (Bofill-
Mas et al., 2000). The first goal of this study was to evaluate
our methods to detect SV40 in the environment by
evaluating the stability of SV40 in sewage samples and by
analyzing the waste of a colony of cynomolgus monkeys
naturally infected with the virus. A second goal of this study
was to characterize the SV40 strains being excreted by the
cynomolgus colony studied.Results
Detection of SV40 in cage waste
The samples from the cages were processed as labeled
samples without identification of the specific cages and
analyzed in two independent assays. Two different sets of
primers that amplify different regions of SV40 genome were
used. SV40 was detected by PCR in the two samples
collected from cages 3 and 4 when the two regions of the
genome were analyzed, the C-terminal of the T-antigen
region, as well as the regulatory region. We semi-quantified
the concentration of viral particles present in the samples by
limiting-dilution nested-PCR experiments. The two samples
of liquids obtained from cage 3, inhabited by three
monkeys, showed approximately 104 genome copies/10 Al
of viral concentrate, which was equivalent to 4 ml of
sample, while the two samples from cage 4, inhabited by
only two monkeys, showed approximately 103 and 101
genome copies/10 Al, respectively, in the viral concentrate
prepared by elution of the viruses present in the total waste
(heterogeneous solid food residues and some liquid excreta)
collected from the cages.
The DNA amplicons from the positive samples were
sequenced without having any information on previously
isolated strains in the colony and confirmed to be SV40.
The strain isolated from cages was designated strain UK
and was further compared, in the two regions studied, to
previously isolated strains and was found to be identical
to strain W17, isolated from 1/19 monkey kidney
biopsies at National Institute for Biological Standards
and Control, UK (NIBSC) (Minor et al., 2001, 2003).
The SV40 UK strain had not been present in our
laboratory before the PCR analysis of the cage waste
was carried out. The strain W17 contains an archetypal
configuration in its regulatory region and is identical to
SV40 strains 777*, Rh911, Pa-57 (previously isolated
from monkey tissues), and to SV40 strains CPC/MEN
and cpc (isolated from human tumors) in its hyper-
variable region, located at the C-terminal of the T-antigen
gene regions (Figs. 1 and 2).Neutralization assays
The results obtained in the SV40 antibody screening
showed that all the monkeys studied in this issue were
seropositive and had a high antibody titer (Table 1).
Cell culture
In order to test the infectivity of the SV40 viral particles
detected and to isolate the SV40 viruses excreted by these
animals, viral concentrates prepared from the environmental
samples positive for SV40 in the PCR assays were
inoculated on CV-1. Cells infected with sample UK8 from
cage 3 showed SV40 cytopatic effect (CPE) within 6 days
postinfection, and cells infected with the 10-fold dilution of
the UK8 viral concentrate showed CPE within 33 days.
Nested-PCR assays confirmed the presence of SV40 in the
supernatant of infected cell cultures, and the analysis of
these supernatants by electron microscopy revealed a co-
infection of SV40 and what appeared to be simian
adenoviruses. The regulatory region of PCR products
obtained from the cell culture was cloned, and five clones
were sequenced and the sequence of these clones was
identical to the previously isolated strain W17 (Minor et al.,
2001, 2003).
Stability of SV40 viral particles in sewage at 20 8C
As there is no previous information on the behavior of
SV40 in the environment, data on the stability of SV40
virions in the environmental waste might contribute to a
better evaluation of their mechanism of transmission.
Comparative analysis of the three samples of raw sewage
from Barcelona and a PBS control, all spiked with SV40
viral particles and kept at 20 8C, showed that the SV40 viral
particles were detected in all the sewage samples until day
40 and in one of them until day 60. The viruses detected
during this time appeared to represent intact virions since
treatment with DNAse prior to nucleic acid extraction did
not eliminate the viral genomes. In evaluating the stability
of SV40 in sewage at 20 8C, we estimated a t90 of 39.9 days
and t99 of 64.7 days. SV40 DNA was detectable in the
spiked PBS control until day 210.Discussion
The breeding colony of cynomolgus colony consists
initially of approximately 24 females and 2 males per
group. A colony due to natural processes may become
occasionally so small that it becomes unviable. When this
occurs, those females that are desirable to retain are either
introduced into another established colony or, if several
depleted colonies exist, they may be amalgamated. Colony
founder animals are identified by number alone, while
those born in the colony are identified by a sequential
Fig. 1. Nucleotide sequences of the T-antigen C-terminal variable domains of strain UK and previously described SV40 strains isolated from monkeys (776,
AF316139; 777*, AY271817; Pa-57, M99362; Rh911, AF316140; K661, AF038616; T302, AF168994; H388, AF168993; I508, AF169000; Kid155,
M99356; Br54, M99351; H328, AF316141; 6593, AF168995; VA45-54-2, AF156105). W17 was isolated from a kidney biopsy of a member of the
cynomolgus colony at NIBSC (Minor et al., 2001). The sequence shown is for the coding strand and numbering is according to SV40 776. Dots indicate
identity to 776 strain and dashes indicate deletion or, when at the beginning or the end of sequences indicate that this part of the sequence is not available at
GenBank.
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394 would be a founder (female) individual, 394A would
be the first offspring and 394B the second. 394AA would
be the offspring of animal 394A whose second offspring
would be 394AB. When the babies are at least 6 months
old and have attained a weight greater than 1 kg, they are
weaned and put together in a gang (groups of about 20
animals) away from the breeding colonies. Juveniles live
in this group until such time as they reach a target weight
of 1.5 kg and are at least 12 months of age. They are then
taken from the gang and caged in small groups of two or
three. It is at this stage that cage waste samples were
collected. The cages were housed in the same room and no
other animals were in the room.
Table 1 shows, as expected, high antibody titers for the
monkeys after being in their group of juveniles for fewweeks, suggesting that SV40 infection spreads between the
monkeys during their stay in the weaned groups and the
seroconversion takes place during gang caging as has been
suggested by Minor et al. (2003) after studying the kinetics
of seroconversion of SV40 in the colony. Transmission
through the environment by the fecal–oral route has been
suggested for monkeys in natural conditions. Most of the
juvenile monkeys in the studied colony seem to be infected
when caged with a high number of other monkeys,
probably because an increase in the probability of contact
between excreted virus and new hosts without the
protection of maternal antibodies. At this stadium is when
we collected the samples and detected 104 genome copies/
4 ml of sample from cage 3 and 103 and 101 genome
copies in the two samples prepared by elution of the
viruses present in the waste (an undetermined quantity of
Fig. 2. Nucleotide sequences of the T-antigen C-terminal variable domains of strain UK and previously described SV40 strains isolated from human tumors
(CPC/MEN, AF156108; Ost9, AF168998; ependy, AF136003; cpc1, AF136000; cpc, AF135999; Ost2, AF168996; cpc2, AF136002; gang, AF136001; Ost3,
AF168997) and SV40 contaminated polio vaccines (MC-028846B, AF18737; Baylor-1, AF155359). The sequence shown is for the coding strand and
numbering is according to SV40 CPC/MEN. Dots indicate identity to CPC/MEN strain and dashes indicate deletion or, when at the beginning or the end of
sequences indicate that this part of the sequence is not available at GenBank.
Rapid Communication4heterogeneous solid food residues and some liquid excreta)
collected from the cage 4.
When analyzing environmental samples from monkey
cages, the possibility of contamination of SV40 strains used
in the laboratory was carefully analyzed. The blind analysis
of the original numbered samples, repeated PCR amplifica-
tion, and isolation of viral particles together with theTable 1
Results obtained in the virus neutralization assays
Group
(samples)
Animal Age
(year)
Birth
colony
Gang
number
Anti-SV40
titer
1 (UK4, UK7) 518HC 1.5 C63 B240 N8192
555FBB 1.3 C56 B240 N8192
2 (UK2, UK5) 020ME 1.3 C63 B242 N8192
436FE 1.1 C25 B240 4096
895H 1.1 C48 B242 8192
3 (UK3, UK8) 394AD 1.1 C37 B242 N8192
930H 1.0 C48 B243 8192
019GD 1.4 C58 B243 N8192
4 (UK1, UK6) 115GH 1.3 C57 B242 8192
N30C 1.5 C64 B240 4096identity, compared at the end of the study, of the identified
sequence, in the C-terminal T-antigen and in the regulatory
region, with the previously described W17, support the
results we have obtained.
In previous studies carried out at NIBSC, cultures of
kidney tissue were set up from 19 seropositive cynomolgus
monkeys. One culture established from animal 586BE
showed typical SV40-like CPE that was evidenced by the
isolation of a SV40 strain identified as W17 (Minor et al.,
2001, 2003).
The sequence identified in the C-terminal T-antigen
variable domain of the strains detected in the cages in these
experiments was identical to the sequence of the W17 SV40
strain and also to sequences previously isolated from
monkeys and humans (Figs. 1 and 2). In 1998, Stewart et
al. described the similarity of some SV40 isolates recovered
from humans as well as from monkeys, and there was no
compelling evidence for human-specific or monkey-specific
SV40 strains. The sequences of the C-terminal T-antigen of
strains Pa-57, Rh911, and CPC/MEN are identical, in the
regions studied, to the strain W17/UK although all have
Rapid Communication 5independent sources. Stewart et al. (1998) and Newman et
al. (1998) also failed to observe tissue-specific differences
among the sequences of the SV40 strains recovered from
different tissues.
The strain identified in this study has been found to have
a single copy of the enhancer in the regulatory region.
However, there is little information about the possible
variety of SV40 strains that might be present in the colony
(Minor et al., 2003). A variety of structures in the regulatory
region could be expected in one animal, or even in the
kidney tissues of one animal, according to data available on
SV40 isolated from monkeys. However, archetypal strains
like the ones described in this study could be the most
common structure of SV40 strains excreted in urine as is the
case for JCV and BKV in humans.
A diversity of SV40 strains isolated from brain, spleen,
and peripheral blood mononuclear cells has been described
in immunocompromised monkeys (Lednicky et al., 1998)
showing the presence of a mixture of diverse archetypal and
nonarchetypal forms, with archetypal SV40 as the predom-
inant form in the monkey brain tissue. Other descriptions of
SV40 strains infecting rhesus monkeys with simian immu-
nodeficiency virus-induced immunodeficiency have been
reported by Ilyinskii et al. (1992). SV40 isolated from
kidney and brain tissues presented an archetypal structure of
the regulatory region as the most common structure in these
tissues. Newman et al. (1998) analyzed the sequence of
SV40 strains isolated from the urine, kidney, and brain of
five SIV-infected and one healthy rhesus monkeys. The
SV40 strains detected in the urine of the healthy animal
presented an archetypal regulatory region as it was the case
of the strains detected in the brain and kidney of SIV-
infected animals, although two of which presented an
archetypal regulatory region variant due to the lack of one
21-bp repeat.
The SV40 strain we identified before and after culture in
CV-1 cells showed stability in its regulatory region in the
first infection and after confirmative culture. In both cases,
these cells were coinfected with SV40 and adenoviruses.
Adenoviruses are viruses commonly detected in the
environment (Bofill-Mas et al., 2000).
To support the probable role of environmental contam-
ination in transmission of SV40 from monkey to monkey
in this colony and in other environments, we examined the
stability of SV40 viral particles in sewage samples at 20
8C. The values we have obtained (t90 of 39.9 days and t99
of 64.7 days) were intermediate to those obtained for the
human polyomaviruses JCV and BKV in previous studies
(Bofill-Mas et al., 2001). It must be taken into account
when considering SV40 stability in the environment that
SV40 DNA was found in SV40-spiked PBS after 210 days
at 20 8C.
The presence of infectious SV40 viral particles in the
environmental waste from 2/4 cynomolgus monkey cages
that we have studied suggests that this contamination
might be a route for the virus to be transmitted. Minor etal. (2003) have presented similar conclusions after
studying the kinetics of seroconversion of the colony.
The most abundant SV40 strains excreted by the colony
of cynomolgus monkeys studied presented a very
homogeneous and stable genetic structure in the RR
and C-terminal T-antigen region. The results confirm the
applicability of the methodology developed for the
detection and isolation of SV40 in environmental
samples, thus our prior failure to detect SV40 in sewage
samples was likely the result of not being present in
detectable levels (Bofill-Mas et al., 2000). Studies of the
presence of this virus in the environment of humans and
macaques that are at this moment been developed by our
research group could provide information on the potential
mechanism of the transmission of SV40 from monkeys to
humans.Materials and methods
Cells and positive controls
SV40 DNA strain 776 (Gibco BRL) was used as a
positive control. CV-1, an African green monkey cell line,
and viral particles of SV40 strain WT 800, were kindly
donated by Dr. Azorin from the Institute Juan de la Cierva,
CSIC (Consejo Superior de Investigaciones Cientı´ficas),
Barcelona. Cells were propagated in Eagle’s minimal
essential medium (EMEM) supplemented with 1% gluta-
mine, 50 Ag of gentamicin/ml, and 5% (growth medium) or
2% (maintenance medium) of heat-inactivated fetal bovine
serum (FBS). The cell line BSC-1 was grown in EMEM
supplemented with 10% fetal bovine serum (FBS) buffered
with 15 mM HEPES. The SV40 strain used in the
neutralization assays was the laboratory strain NIBSC
isolated in the 1960s (Sangar et al., 1999).
Environmental samples
A total of eight samples were obtained from four
different cynomolgus monkey (Macaca fascicularis) cages
over a 24-h period (two samples per cage) at the National
Institute for Biological Standards and Control, UK
(NIBSC). Samples contained excrements, urine, and resi-
dues of food. These samples were frozen at 20 8C and
shipped to Spain for further analysis.
Serum samples and virus neutralization assay
As part of the general health check, a 2-ml blood
sample was removed from the monkeys femoral vein and
transferred into a suitable container without anti-coagulant.
The serum was removed from the clotted blood sample
and held at 56 8C for 30 min, this reduced or removed any
toxic effect to the BSC-1 cells. The serum was then stored
at 20 8C until use. The virus dose was established by
Rapid Communication6titration in BSC-1 cells as previously described (Minor
et al., 2003).
Concentration of viral particles from environmental
samples from monkey’s cages
Recovery of viral particles obtained from monkey cages
was carried out in two ways depending on the character-
istics of each sample. Liquid samples were processed as
sewage as described in previous studies (Puig et al., 1994).
Solid samples were dissolved with 4 ml of 0.25 N glycine
buffer pH 9.5 using magnetic stirring for 30 min, the
suspended solids were separated by centrifugation at
12000  g for 15 min after the addition of 4 ml of 2
PBS. Viruses were pelleted by ultracentrifugation (229600
 g for 1 h at 4 8C), resuspended in 0.1 ml of 1 PBS,
and stored at 80 8C.
Stability of SV40 viral particles in sewage
One liter of raw sewage sample was collected in the area
of Barcelona (Spain) in a sterile polyethylene container and
kept at 4 8C for less than 8 h until it was spiked with SV40
WT800 viral particles and divided into three sterile beakers.
Beakers were kept in an oven at 20 8C. One liter of PBS
spiked with SV40 WT800 viral particles was used as a
positive control. Aliquots of 40 ml of each sample were
concentrated at days 0, 10, 30, 40, 60, and 210 as described
in the previous section. The presence of viral particles was
evaluated by nested PCR and, to determine if the viral
particles remained intact, viral concentrates were treated
with DNAse as previously described (Bofill-Mas et al.,
2001). The estimated concentration of SV40 viral particles
in the samples was carried out by nested PCR limiting-
dilution assays.
In order to obtain an estimated t90 and t99 (time required
for a 90% and 99% reduction in the viral concentration), we
computed a linear regression model with the logarithm of
the estimated concentration of viral particles detected by
nested PCR expressed as PCR-genomic equivalents. The
method applied had been previously applied and describedTable 2
Oligonucleotide primers used for PCR amplification and sequencing of SV40
Virus type (region) Position Primers Size (bp)
SV40 (Tag)a 2609–2631b SV1A 458
SV40 (Tag) 3036–3058 SV
SV40 (Tag) 2746–2766 SV5 255
SV40 (Tag) 2980–3000 SVN
SV40 (RR)a 358–336 RA3c 482
SV40 (RR) 5119–5142 RA4c
SV40 (RR) 266–245 RA1c 314
SV40 (RR) 5195–5218 RA2c
a Tag, C-terminal T-antigen region; RR, regulatory region; AT, annealing temper
b The sequence positions are referred to SV40 strain 776.
c From Lednicky et al. (1995).when studying the stability of human polyomaviruses JCV
and BKV (Bofill-Mas et al., 2001).
Enzymatic amplification and sequencing of the PCR
products
Viral nucleic acids were extracted using a procedure that
uses guanidinium thiocyanate (GuSCN) and adsorption of
the nucleic acids to silica particles (Boom et al., 1990),
providing clean nucleic acids for genomic amplification.
Ten-microliter aliquots of the extracted nucleic acids were
used in each test. Amplifications were carried out as
previously described for SV40 and human polyomaviruses
JCV and BKV (Bofill-Mas et al., 2000, 2001). Primers and
annealing temperatures used in this study are represented in
Table 2. The results were analyzed by agarose gel electro-
phoresis using ethidium bromide staining.
Direct and 10-fold dilutions of the samples were
analyzed, and the assays for detection of the presence of
SV40 in samples from monkey cages were carried out three
times in independent experiments for the confirmation of the
results using two different sets of primers that amplify two
different regions of the SV40 genome, the regulatory and
the C-terminal T-antigen regions. Standard precautions were
applied in all the manipulations in order to reduce the
probability of sample contamination by amplified DNA
molecules. Products obtained after PCR were purified and
both strains automatically sequenced as previously des-
cribed (Bofill-Mas et al., 2000).
Infection of CV-1 cells
Concentrates of the samples positive for SV40 by PCR
were diluted 1:10 in PBS and filtered using 0.22 Am low
protein binding Durapore syringe-driven filters (MillexR-
GV, Millipore) in order to eliminate any bacteria remaining
in the concentrate.
One hundred microliters of the filtrates obtained was
used to infect cells plated on 25-cm2 flasks. PBS was
inoculated in cell culture as negative controls. After 1 h at
37 8C, maintenance medium was added. Supernatants wereATa (8C) Sequence
55 5V-TGTGAAATTTGTGATGCTATTGC-3V
5V-AGTTTGCTCAAAGTATTCAGAGC-3V
46 5V-CTACARATGTGRTATGGCTGA-3Va
5V-GTTTAGTTTGTCAGTGTATCA-3V
59 5V-GCGTGACAGCCGGCGCAGCACCA-3
5V-GTCCATTAGCTGCAAAGATTCCTC-3
55 5V-AATGTGTGTCAGTTAGGGTGTG-3V
5V-TCCAAAAAAGCCTCCTCACTACTT-3
ature; R, A + G.V
V
V
Rapid Communication 7renewed weekly using maintenance medium and stored at
80 8C for further studies. The time course of the infection
was examined by observation of CPE. Stored supernatants
of different days postinfection were assayed by PCR.
Positive results were confirmed by cell culture, cloning,
and sequencing of the progeny virions.
Cloning of the regulatory region of SV40
The regulatory regions of the SV40 growing in cell
culture and present in the supernatant of CV-1 cells were
amplified by nested PCR. Bands obtained were purified
with the QUIAquick PCR purification kit (QIAGEN, Inc.).
Purified bands were cloned as previously done with other
polyomaviruses (Bofill-Mas et al., 2001). The inserts were
recovered by PCR amplification using primers RA and RA2
(Table 2). Products obtained after the PCR were further
analyzed by sequencing using the amplification primers.Acknowledgments
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